Latest News for: psoriasis

Edit

Music Icon Art Garfunkel Opens Up About His Experience with Psoriasis for The First Time ...

The Bradford Era 05 Apr 2025
8X Grammy Award-winning artist and Rock and Roll Hall of Fame inductee reveals his experience with ILUMYA®(tildrakizumab-asmn) as part of the "I LUV YA for The Long Haul" campaign ....
Edit

Art Garfunkel Opens Up on Longtime Struggle With Psoriasis

The Epoch Times 05 Apr 2025
“Psoriasis is something I lived with quietly for many years.
Edit

Art Garfunkel breaks his silence on lifelong psoriasis struggle as he embraces a new chapter

The Times of India 05 Apr 2025
For the first time in years, he felt liberated from the need to conceal his psoriasis, marking a transformative phase in his life ... This initiative aims to raise awareness about psoriasis, emphasizing ...
Edit

Music Icon Art Garfunkel Opens Up About His Experience with Psoriasis for The First Time in Partnership with Sun Pharma

PR Newswire 04 Apr 2025
About Plaque Psoriasis Plaque psoriasis is a chronic, autoimmune disease that results in an overactive immune system and causes inflammation in the body, leading to symptoms like plaques, redness and flakes.
Edit

PEPITEM sequence shows effects in psoriasis, comparable to steroid cream

Science Daily 03 Apr 2025
Scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream ... .
Edit

REIG JOFRE and LEO PHARMA join forces to improve access to an innovative psoriasis treatment in Primary Care (Laboratorio Reig Jofre SA)

Public Technologies 26 Mar 2025
) REIG JOFRE and LEO PHARMA join forces to improve access to an innovative psoriasis treatment in Primary Care ... In the topical treatment market for psoriasis, this therapy stands out as the undisputed leader both in Spain and across Europe.
Edit

Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & ...

Nasdaq Globe Newswire 24 Mar 2025
The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs ... .
Edit

Can Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA Approved Protocol (Can Fite Biofpharma Ltd)

Public Technologies 24 Mar 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 123210088) .
Edit

Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol (Form 6-K) (Can Fite Biofpharma Ltd)

Public Technologies 24 Mar 2025
Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug ... The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs ... The study will enroll patients with moderate to severe plaque psoriasis.
Edit

'I found a miracle fix for my psoriasis - it's completely changed my life'

The Mirror 22 Mar 2025
A mother-of-two claims to have found a "miracle" cure for her psoriasis almost three decades after first being diagnosed with the skin condition that causes rashes over the body ... .
Edit

National Psoriasis Foundation Offers People With Psoriasis A Way To Cōpe

MENA FN 21 Mar 2025
(MENAFN - EIN Presswire) ALEXANDRIA, VA, UNITED STATES, March 20, 2025 /EINPresswire / -- The National Psoriasis Foundation (NPF) is pleased to announce a special offer made possible by our ... .
  • 1

Article Search

tools
×
×
×
×